Related Articles
Uncommon gastrointestinal bleeding during targeted therapy for advanced renal cell carcinoma: A report of four cases
Efficacy and safety of sorafenib in advanced renal cell carcinoma patients: Results from a long-term study
5‑fluorouracil enhances the antitumor effect of sorafenib and sunitinib in a xenograft model of human renal cell carcinoma
A combination of sorafenib and radiotherapy reduces NF‑κB activity and growth of hepatocellular carcinoma in an orthotopic mouse model
Sorafenib‑based therapy in HER2‑negative advanced breast cancer: Results from a retrospective pooled analysis of randomized controlled trials